Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2061-2076
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2061
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2061
Figure 3 Forest plots on the assessment of progression-free survival in biliary tract cancer patients treated with chemotherapy + targeted therapy or chemotherapy alone.
A: Overall population; B: Subgroup analysis according to agent targets; C: Subgroup analysis according to chemotherapy regimens. EGFR: Epidermal growth factor receptor; VEGFR: Vascular endothelial growth factor receptor; MET: Mesenchymal-epithelial transition factor.
- Citation: Bai XS, Zhou SN, Jin YQ, He XD. Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis. World J Gastrointest Oncol 2022; 14(10): 2061-2076
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/2061.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.2061